NCT00045175 2016-06-23
UCN-01 and Topotecan in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer
University Health Network, Toronto
Phase 1 Completed
Clinical Trials
8 trialsNCT00045513 2015-07-23
Combination Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma
University Health Network, Toronto
Phase 1/2 Completed
NCT00072267 2015-07-23
UCN-01 and Topotecan in Treating Patients With Recurrent, Persistent, or Progressive Advanced Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
University Health Network, Toronto
Phase 2 Completed
NCT00004059 2013-06-21
Fluorouracil Plus UCN-01 in Treating Patients With Advanced or Refractory Solid Tumors
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT00004263 2012-07-30
Cytarabine and UCN-01 in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Myelodysplastic Syndrome
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00003289 2010-08-09
UCN-01 in Treating Patients With Advanced Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Completed
NCT00047242 2010-08-09
UCN-01 and Irinotecan in Treating Patients With Advanced Solid Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Completed
NCT00006464 2010-01-15
UCN-01 and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors
City of Hope Medical Center
Phase 1 Completed